Saltar al contenido
Merck

Fever and leukocytosis related to terconazole vaginal suppository.

Southern medical journal (1994-07-01)
S S Hyder, J E Manjon, N M Gantz
RESUMEN

We describe a 22-year-old woman who developed fever, shaking chills, and leukocytosis after insertion of a terconazole (80 mg) vaginal suppository for mild vaginal candidiasis. The patient became afebrile and asymptomatic 24 hours after hospital admission without antibiotic therapy. More experience with terconazole is needed before it can be considered as safe as other imidazole derivatives that have been available for more than 15 years.

MATERIALES
Referencia del producto
Marca
Descripción del producto

USP
Terconazole, United States Pharmacopeia (USP) Reference Standard
Supelco
Terconazole, VETRANAL®, analytical standard
Terconazole, European Pharmacopoeia (EP) Reference Standard